Study Summary:
A clinical trial evaluating the effects of Fluticasone Furoate/Vilanterol Inhalation Powder with Placebo in patients with COPD and increased risk of heart disease.
Qualified Participants Must:
• Be between 40 and 80 years of age
•
Be diagnosed with COPD
•
Not currently have Asthma
Qualified Participants May Receive:
Compensation for time and travel for completed visits.